Similarly, serum VEGF levels in MCAO rats treated with Neuroncell-EX 2 × 106 cells/rat and Neuroncell-EX 4 × 106 cells/rat were significantly lower at day 4 compared to stroke control (163.48 ± 5.35 ρg/mL; p = 0.002 and 158.85 ± 2.30 ρg/mL; p < 0.0001 versus 189.6 ± 5.50 ρg/mL, respectively). The gene discussed is VEGFA; the disease is Stroke.